Standout Papers

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial 1999 2026 2008 2017 550
  1. Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial (1999)
    J. Durant, Philippe Clevenbergh et al. The Lancet

Immediate Impact

5 by Nobel laureates 28 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
2022 StandoutNature
Bayesian reaction optimization as a tool for chemical synthesis
2021 StandoutNature
3 intermediate papers

Works of Philippe Halfon being referenced

Hepatitis C virus resistance to protease inhibitors
2011
Synthesis of (±) cis-substituted cyclohexenyl and cyclohexanyl nucleosides via a double Mitsunobu-type reaction
2002

Author Peers

Author Last Decade Papers Cites
Philippe Halfon 4597 3967 2353 222 7.6k
F. Blaine Hollinger 5331 4518 1708 164 7.8k
Kenneth E. Sherman 5666 6561 2119 247 8.5k
Michael Robertson 3221 2205 2137 136 6.3k
Shyam Kottilil 3722 3061 1844 208 7.5k
Sugantha Govindarajan 6573 7791 2007 181 10.3k
Hung‐Chih Yang 3666 3124 1593 177 7.1k
Jacquie Astemborski 4517 3428 1975 115 7.0k
Massimo Puoti 6448 6830 2417 256 8.9k
M. Elaine Eyster 2096 1709 1474 123 5.0k
Jean‐Pierre Allain 4296 3768 1516 224 7.1k

All Works

Loading papers...

Rankless by CCL
2026